| Original language | English (US) |
|---|---|
| Pages (from-to) | 517-530 |
| Number of pages | 14 |
| Journal | Clinics in Chest Medicine |
| Volume | 42 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 2021 |
Keywords
- Cystic fibrosis
- Hormones
- Menopause
- Puberty
- Sex differences
- Sexual and reproductive health
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Clinics in Chest Medicine, Vol. 42, No. 3, 09.2021, p. 517-530.
Research output: Contribution to journal › Review article › peer-review
}
TY - JOUR
T1 - Challenges Faced by Women with Cystic Fibrosis
AU - Jain, Raksha
AU - Kazmerski, Traci M.
AU - Aitken, Moira L.
AU - West, Natalie
AU - Wilson, Alexandra
AU - Bozkanat, Kubra M.
AU - Montemayor, Kristina
AU - von Berg, Karen
AU - Sjoberg, Jacqui
AU - Poranski, Maddie
AU - Taylor-Cousar, Jennifer L.
N1 - Funding Information: The authors would like to thank the CF Foundation for support of the Women’s Health Research Working Group. Funding Information: R. Jain receives consulting fees from Vertex Pharmaceuticals, Boehringer Ingelheim, and the CF Foundation unrelated to this work as well as grant support from the CF Foundation , Sound Pharmaceuticals , Genentech , Vertex Pharmaceuticals , Corbus , and Boehringer Ingelheim . T.M. Kazmerski receives consulting fees from the CF Foundation unrelated to this work as well as grant support from the CF Foundation and the Patient-Centered Outcomes Research Institute . K. Montemayor receives grant support from the CF Foundation and Johns Hopkins-Specialized Center for Research Excellence (SCORE) in Sex and Age Differences in Immunity to Influenza (SADII) and The Foundation for Gender-Specific Medicine . K. von Berg receives grant support and consulting fees from the CF Foundation, unrelated to this work. N. West receives consulting fees from Vertex Pharmaceuticals unrelated to this work, as well as grant support from the CF Foundation and Corbus. J.L. Taylor-Cousar receives grant support from Vertex Pharmaceutical, Proteostasis, Eloxx, and the CF Foundation as well as personal fees from Proteostasis, Santhera, 4DMT, Polarean, and Vertex for consulting, along with speaking fees from Vertex Pharmaceuticals unrelated to this work.
PY - 2021/9
Y1 - 2021/9
KW - Cystic fibrosis
KW - Hormones
KW - Menopause
KW - Puberty
KW - Sex differences
KW - Sexual and reproductive health
UR - http://www.scopus.com/inward/record.url?scp=85111598018&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111598018&partnerID=8YFLogxK
U2 - 10.1016/j.ccm.2021.04.010
DO - 10.1016/j.ccm.2021.04.010
M3 - Review article
C2 - 34353456
AN - SCOPUS:85111598018
SN - 0272-5231
VL - 42
SP - 517
EP - 530
JO - Clinics in Chest Medicine
JF - Clinics in Chest Medicine
IS - 3
ER -